About
CAGE Bio Inc., currently a resident company at Johnson & Johnson Innovation, JLABS @ MBC BioLabs, is a clinical-stage startup exploiting its proprietary deep eutectic ionic liquid platform to develop novel products for dermatology, inflammation, and immunology.
We believe that systemic exposure to drugs should be an exception. Our mission is to develop highly effective products for localized treatment thereby minimizing side effects from systemic exposure.